Baxter International (BAX) Capital Expenditures (2009 - 2026)

Baxter International (BAX) has 18 years of Capital Expenditures data on file, last reported at $137.0 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $137.0 million, up 12.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $528.0 million (up 15.28% YoY), and the FY2025 annual result was $513.0 million, up 15.02% from the prior year.
• Capital Expenditures declined to $137.0 million in Q1 2026 per BAX's latest filing, from $140.0 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $165.0 million in Q1 2023 and troughed at -$61.0 million in Q4 2022.
• A 5-year average of $112.1 million and a median of $134.0 million in 2024 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures slumped 133.33% in 2022, then soared 1016.67% in 2024.
• A 5-year view of Capital Expenditures shows it stood at -$61.0 million in 2022, then soared by 250.82% to $92.0 million in 2023, then surged by 43.48% to $132.0 million in 2024, then advanced by 6.06% to $140.0 million in 2025, then dropped by 2.14% to $137.0 million in 2026.
• Business Quant data shows BAX's Capital Expenditures at $137.0 million in Q1 2026, $140.0 million in Q4 2025, and $111.0 million in Q3 2025.